MANUFACTURER: BioCryst Pharmaceuticals

USAGE: Oral

MEDICINE APPROVED BY:

European Medical Agency (EMA)

Food and Drug Administration (FDA)

Pharmaceuticals and Medical Devices Agency (PMDA)

Orladeyo is a prescription medication used to prevent attacks of hereditary angioedema by reducing the production of bradykinin, which causes swelling and inflammation. It was approved by the FDA in 2020 and is taken orally once daily.